A detailed history of Planned Solutions, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Planned Solutions, Inc. holds 240 shares of OGN stock, worth $3,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares
240
Holding current value
$3,588
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$18.65 - $23.03 $4,476 - $5,527
240 New
240 $4,000
Q4 2023

Jan 17, 2024

BUY
$10.95 - $17.32 $2,496 - $3,948
228 New
228 $3,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.8B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Planned Solutions, Inc. Portfolio

Follow Planned Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planned Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Planned Solutions, Inc. with notifications on news.